Abstract
This review focuses on the MRI features of neurogenic tumors and rhabdomyosarcoma in children. Neurogenic tumors include those arising from a nerve sheath and neuroblastic tumors that arise from the sympathetic nervous system. Nerve sheath tumors can be benign or malignant and occur sporadically or in association with neurofibromatosis type 1. Neuroblastic tumors comprise a spectrum of tumors ranging from highly malignant neuroblastoma to the benign ganglioneuroma. These neurogenic tumors arise in typical locations within the chest, abdomen and pelvis and have distinctive and characteristic imaging features that should suggest their diagnosis. Rhabdomyosarcoma encompasses a variety of histological subtypes that exhibit varying degrees of aggressiveness and biological behavior. While some abdominal and pelvic locations are well known to give rise to rhabdomyosarcoma, this tumor can arise in any tissue in the body except bone. The paper reviews the MRI and clinical features of neurogenic tumors and rhabdomyosarcoma and the imaging findings that can aid in clinical management.
Similar content being viewed by others
References
Laffan EE, Ngan BY, Navarro OM (2009) Pediatric soft-tissue tumors and pseudotumors: MR imaging features with pathologic correlation: part 2. Tumors of fibroblastic/myofibroblastic, so-called fibrohistiocytic, muscular, lymphomatous, neurogenic, hair matrix, and uncertain origin. Radiographics 29:e36
Kao SC-S, Parha DM, Fuller C (2015) Malignant tumors of peripheral nerves. In: Parham DM, Khoury JD, McCarville MB (eds) Pediatric malignancies: pathology and imaging. Springer, New York, pp 399–414
Ahlawat S, Chhabra A, Blakely J (2014) Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am 24:171–192
Slattery WH (2015) Neurofibromatosis type 2. Otolaryngol Clin North Am 48:443–460
Ferner RE, O’Doherty MJ (2002) Neurofibroma and schwannoma. Curr Opin Neurol 15:679–684
Amirian ES, Goodman JC, New P et al (2014) Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program. J Neurooncol 116:609–616
Bates JE, Peterson CR, Dhakal S et al (2014) Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. Pediatr Blood Cancer 61:1955–1960
Murphey MD, Smith WS, Smith SE et al (1999) From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics 19:1253–1280
Mautner VF, Friedrich RE, von Deimling A et al (2003) Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 45:618–625
Lin J, Martel W (2001) Cross-sectional imaging of peripheral nerve sheath tumors: characteristic signs on CT, MR imaging, and sonography. AJR Am J Roentgenol 176:75–82
Matsumine A, Kusuzaki K, Nakamura T et al (2009) Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI. J Cancer Res Clin Oncol 135:891–900
Lonergan GJ, Schwab CM, Suarez ES et al (2002) Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 22:911–934
McCarville MB (2011) Imaging neuroblastoma: what the radiologist needs to know. Cancer Imaging 11:S44–S47
Brisse HJ, McCarville MB, Granata C et al (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 261:243–257
Brodeur GM, Pritchard J, Berthold F et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466–1477
Monclair T, Brodeur GM, Ambros PF et al (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG task force report. J Clin Oncol 27:298–303
Kembhavi SA, Shah S, Rangarajan V et al (2015) Imaging in neuroblastoma: an update. Indian J Radiol Imaging 25:129–136
Irtan S, Brisse HJ, Minard-Colin V et al (2015) Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection. Pediatr Blood Cancer 62:1543–1549
Geoerger B, Hero B, Harms D et al (2001) Metabolic activity and clinical features of primary ganglioneuromas. Cancer 91:1905–1913
Stein-Wexler R (2011) Pediatric soft tissue sarcomas. Semin Ultrasound CT MR 32:470–488
Wexler LH, Meyer WH, Helman LJ (2011) Rhabdomyosarcoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott Williams & Wilkins, Philadelphia
Swinson S, McHugh K (2011) Urogenital tumours in childhood. Cancer Imaging 11:S48–S64
Ferrari A, Bisogno G, Casanova M et al (2004) Is alveolar histotype a prognostic factor in paratesticular rhabdomyosarcoma? The experience of Italian and German Soft Tissue Sarcoma Cooperative Group. Pediatr Blood Cancer 42:134–138
Anderson JR, Meyer WH, Wiener ES (2004) Favorable outcome for children with paratesticular alveolar history rhabdomyosarcoma. Pediatr Blood Cancer 43:180
Lack EE, Perez-Atayde AR, Schuster SR (1981) Botryoid rhabdomyosarcoma of the biliary tract. Am J Surg Pathol 5:643–652
Stein-Wexler R (2009) MR imaging of soft tissue masses in children. Magn Reson Imaging Clin N Am 17:489–507
Pai DR, Ladino-Torres MF (2013) Magnetic resonance imaging of pediatric pelvic masses. Magn Reson Imaging Clin N Am 21:751–772
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The author has no financial interests, investigational or off-label uses to disclose.
Rights and permissions
About this article
Cite this article
McCarville, M.B. What MRI can tell us about neurogenic tumors and rhabdomyosarcoma. Pediatr Radiol 46, 881–890 (2016). https://doi.org/10.1007/s00247-016-3572-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-016-3572-4